Logo image of SLP

SIMULATIONS PLUS INC (SLP) Stock Fundamental Analysis

USA - NASDAQ:SLP - US8292141053 - Common Stock

18.31 USD
+0.15 (+0.83%)
Last: 10/28/2025, 8:22:15 PM
18.01 USD
-0.3 (-1.64%)
After Hours: 10/28/2025, 8:22:15 PM
Fundamental Rating

6

Overall SLP gets a fundamental rating of 6 out of 10. We evaluated SLP against 35 industry peers in the Health Care Technology industry. SLP is in great health and has no worries on liquidiy or solvency at all, but the profibility rating is only average. SLP is valued quite expensively, but it does show have an excellent growth rating.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

In the past year SLP was profitable.
In the past year SLP had a positive cash flow from operations.
Each year in the past 5 years SLP has been profitable.
SLP had a positive operating cash flow in each of the past 5 years.
SLP Yearly Net Income VS EBIT VS OCF VS FCFSLP Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M

1.2 Ratios

The Return On Assets of SLP (-47.03%) is worse than 77.14% of its industry peers.
SLP has a Return On Equity of -51.05%. This is comparable to the rest of the industry: SLP outperforms 45.71% of its industry peers.
SLP has a better Return On Invested Capital (3.12%) than 77.14% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for SLP is below the industry average of 6.80%.
Industry RankSector Rank
ROA -47.03%
ROE -51.05%
ROIC 3.12%
ROA(3y)5.68%
ROA(5y)5.6%
ROE(3y)6.11%
ROE(5y)6.04%
ROIC(3y)4.57%
ROIC(5y)5.03%
SLP Yearly ROA, ROE, ROICSLP Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15 20 25

1.3 Margins

SLP's Profit Margin has declined in the last couple of years.
SLP's Operating Margin of 5.82% is fine compared to the rest of the industry. SLP outperforms 71.43% of its industry peers.
SLP's Operating Margin has declined in the last couple of years.
Looking at the Gross Margin, with a value of 53.75%, SLP is in line with its industry, outperforming 42.86% of the companies in the same industry.
In the last couple of years the Gross Margin of SLP has declined.
Industry RankSector Rank
OM 5.82%
PM (TTM) N/A
GM 53.75%
OM growth 3Y-28.77%
OM growth 5Y-22.51%
PM growth 3Y-12.26%
PM growth 5Y-10.86%
GM growth 3Y-7.23%
GM growth 5Y-3.44%
SLP Yearly Profit, Operating, Gross MarginsSLP Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20 40 60 80

8

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so SLP is destroying value.
SLP has more shares outstanding than it did 1 year ago.
SLP has more shares outstanding than it did 5 years ago.
SLP has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
SLP Yearly Shares OutstandingSLP Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M
SLP Yearly Total Debt VS Total AssetsSLP Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M

2.2 Solvency

An Altman-Z score of 21.63 indicates that SLP is not in any danger for bankruptcy at the moment.
The Altman-Z score of SLP (21.63) is better than 91.43% of its industry peers.
SLP has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 21.63
ROIC/WACC0.32
WACC9.84%
SLP Yearly LT Debt VS Equity VS FCFSLP Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M

2.3 Liquidity

SLP has a Current Ratio of 5.11. This indicates that SLP is financially healthy and has no problem in meeting its short term obligations.
SLP has a better Current ratio (5.11) than 88.57% of its industry peers.
SLP has a Quick Ratio of 5.11. This indicates that SLP is financially healthy and has no problem in meeting its short term obligations.
With an excellent Quick ratio value of 5.11, SLP belongs to the best of the industry, outperforming 88.57% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 5.11
Quick Ratio 5.11
SLP Yearly Current Assets VS Current LiabilitesSLP Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M

7

3. Growth

3.1 Past

SLP shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 38.30%, which is quite impressive.
The Earnings Per Share has been growing slightly by 0.41% on average over the past years.
Looking at the last year, SLP shows a very strong growth in Revenue. The Revenue has grown by 20.01%.
The Revenue has been growing by 15.56% on average over the past years. This is quite good.
EPS 1Y (TTM)38.3%
EPS 3Y2.13%
EPS 5Y0.41%
EPS Q2Q%200%
Revenue 1Y (TTM)20.01%
Revenue growth 3Y14.64%
Revenue growth 5Y15.56%
Sales Q2Q%9.81%

3.2 Future

SLP is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 21.41% yearly.
Based on estimates for the next years, SLP will show a quite strong growth in Revenue. The Revenue will grow by 9.89% on average per year.
EPS Next Y-608.71%
EPS Next 2Y-8.3%
EPS Next 3Y4.21%
EPS Next 5Y21.41%
Revenue Next Year9.94%
Revenue Next 2Y6.37%
Revenue Next 3Y6.33%
Revenue Next 5Y9.89%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
SLP Yearly Revenue VS EstimatesSLP Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 50M 100M 150M
SLP Yearly EPS VS EstimatesSLP Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 1 -1 -2

3

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 28.17, SLP can be considered very expensive at the moment.
85.71% of the companies in the same industry are more expensive than SLP, based on the Price/Earnings ratio.
SLP is valuated at similar levels of the S&P average when we compare the Price/Earnings ratio to 27.00, which is the current average of the S&P500 Index.
The Price/Forward Earnings ratio is 44.43, which means the current valuation is very expensive for SLP.
The rest of the industry has a similar Price/Forward Earnings ratio as SLP.
When comparing the Price/Forward Earnings ratio of SLP to the average of the S&P500 Index (22.87), we can say SLP is valued expensively.
Industry RankSector Rank
PE 28.17
Fwd PE 44.43
SLP Price Earnings VS Forward Price EarningsSLP Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, SLP is valued a bit cheaper than the industry average as 71.43% of the companies are valued more expensively.
74.29% of the companies in the same industry are more expensive than SLP, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 34.94
EV/EBITDA 24.64
SLP Per share dataSLP EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)68.17
EPS Next 2Y-8.3%
EPS Next 3Y4.21%

4

5. Dividend

5.1 Amount

With a yearly dividend of 0.61%, SLP is not a good candidate for dividend investing.
SLP's Dividend Yield is rather good when compared to the industry average which is at 4.92. SLP pays more dividend than 94.29% of the companies in the same industry.
Compared to an average S&P500 Dividend Yield of 2.31, SLP's dividend is way lower than the S&P500 average.
Industry RankSector Rank
Dividend Yield 0.61%

5.2 History

The dividend of SLP has a limited annual growth rate of 0.01%.
SLP has paid a dividend for at least 10 years, which is a reliable track record.
Dividend Growth(5Y)0.01%
Div Incr Years0
Div Non Decr Years0
SLP Yearly Dividends per shareSLP Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0.05 0.1 0.15 0.2

5.3 Sustainability

SLP has negative earnings and hence a negative payout ratio. The dividend may be in danger.
The dividend of SLP is growing, but earnings are growing more, so the dividend growth is sustainable.
DP-1.9%
EPS Next 2Y-8.3%
EPS Next 3Y4.21%
SLP Yearly Income VS Free CF VS DividendSLP Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M

SIMULATIONS PLUS INC

NASDAQ:SLP (10/28/2025, 8:22:15 PM)

After market: 18.01 -0.3 (-1.64%)

18.31

+0.15 (+0.83%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Technology
Earnings (Last)10-22 2025-10-22/amc
Earnings (Next)01-05 2026-01-05
Inst Owners86.07%
Inst Owner Change-2.74%
Ins Owners17.37%
Ins Owner Change-1.85%
Market Cap368.58M
Revenue(TTM)80.38M
Net Income(TTM)-63194000
Analysts80
Price Target23.46 (28.13%)
Short Float %6.73%
Short Ratio2.11
Dividend
Industry RankSector Rank
Dividend Yield 0.61%
Yearly Dividend0.24
Dividend Growth(5Y)0.01%
DP-1.9%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)160.9%
Min EPS beat(2)0.69%
Max EPS beat(2)321.12%
EPS beat(4)2
Avg EPS beat(4)55.29%
Min EPS beat(4)-90.66%
Max EPS beat(4)321.12%
EPS beat(8)3
Avg EPS beat(8)16.77%
EPS beat(12)4
Avg EPS beat(12)5.67%
EPS beat(16)7
Avg EPS beat(16)7.48%
Revenue beat(2)2
Avg Revenue beat(2)0.96%
Min Revenue beat(2)0.63%
Max Revenue beat(2)1.3%
Revenue beat(4)2
Avg Revenue beat(4)-1.21%
Min Revenue beat(4)-6.39%
Max Revenue beat(4)1.3%
Revenue beat(8)5
Avg Revenue beat(8)-0.3%
Revenue beat(12)6
Avg Revenue beat(12)-0.44%
Revenue beat(16)10
Avg Revenue beat(16)1.72%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)-9.09%
EPS NQ rev (3m)-1946.15%
EPS NY rev (1m)-8.72%
EPS NY rev (3m)-907.19%
Revenue NQ rev (1m)-0.44%
Revenue NQ rev (3m)-8.77%
Revenue NY rev (1m)-0.08%
Revenue NY rev (3m)-5.88%
Valuation
Industry RankSector Rank
PE 28.17
Fwd PE 44.43
P/S 4.59
P/FCF 34.94
P/OCF 25.95
P/B 2.98
P/tB 7.35
EV/EBITDA 24.64
EPS(TTM)0.65
EY3.55%
EPS(NY)0.41
Fwd EY2.25%
FCF(TTM)0.52
FCFY2.86%
OCF(TTM)0.71
OCFY3.85%
SpS3.99
BVpS6.15
TBVpS2.49
PEG (NY)N/A
PEG (5Y)68.17
Graham Number9.48
Profitability
Industry RankSector Rank
ROA -47.03%
ROE -51.05%
ROCE 3.77%
ROIC 3.12%
ROICexc 4.04%
ROICexgc 17.48%
OM 5.82%
PM (TTM) N/A
GM 53.75%
FCFM 13.12%
ROA(3y)5.68%
ROA(5y)5.6%
ROE(3y)6.11%
ROE(5y)6.04%
ROIC(3y)4.57%
ROIC(5y)5.03%
ROICexc(3y)12.97%
ROICexc(5y)16.03%
ROICexgc(3y)84.29%
ROICexgc(5y)97.41%
ROCE(3y)5.53%
ROCE(5y)6.08%
ROICexgc growth 3Y-24.94%
ROICexgc growth 5Y-20.15%
ROICexc growth 3Y-47.05%
ROICexc growth 5Y-36.7%
OM growth 3Y-28.77%
OM growth 5Y-22.51%
PM growth 3Y-12.26%
PM growth 5Y-10.86%
GM growth 3Y-7.23%
GM growth 5Y-3.44%
F-Score4
Asset Turnover0.6
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 40.33%
Cap/Sales 4.55%
Interest Coverage 250
Cash Conversion 103.33%
Profit Quality N/A
Current Ratio 5.11
Quick Ratio 5.11
Altman-Z 21.63
F-Score4
WACC9.84%
ROIC/WACC0.32
Cap/Depr(3y)99.44%
Cap/Depr(5y)102.61%
Cap/Sales(3y)6.89%
Cap/Sales(5y)7.35%
Profit Quality(3y)126.28%
Profit Quality(5y)123.52%
High Growth Momentum
Growth
EPS 1Y (TTM)38.3%
EPS 3Y2.13%
EPS 5Y0.41%
EPS Q2Q%200%
EPS Next Y-608.71%
EPS Next 2Y-8.3%
EPS Next 3Y4.21%
EPS Next 5Y21.41%
Revenue 1Y (TTM)20.01%
Revenue growth 3Y14.64%
Revenue growth 5Y15.56%
Sales Q2Q%9.81%
Revenue Next Year9.94%
Revenue Next 2Y6.37%
Revenue Next 3Y6.33%
Revenue Next 5Y9.89%
EBIT growth 1Y-33.13%
EBIT growth 3Y-18.34%
EBIT growth 5Y-10.46%
EBIT Next Year145.07%
EBIT Next 3Y49.49%
EBIT Next 5Y49.82%
FCF growth 1Y-52.99%
FCF growth 3Y-14.87%
FCF growth 5Y-1.4%
OCF growth 1Y-46.86%
OCF growth 3Y-11.47%
OCF growth 5Y2.73%

SIMULATIONS PLUS INC / SLP FAQ

What is the ChartMill fundamental rating of SIMULATIONS PLUS INC (SLP) stock?

ChartMill assigns a fundamental rating of 6 / 10 to SLP.


What is the valuation status for SLP stock?

ChartMill assigns a valuation rating of 3 / 10 to SIMULATIONS PLUS INC (SLP). This can be considered as Overvalued.


How profitable is SIMULATIONS PLUS INC (SLP) stock?

SIMULATIONS PLUS INC (SLP) has a profitability rating of 4 / 10.


What are the PE and PB ratios of SIMULATIONS PLUS INC (SLP) stock?

The Price/Earnings (PE) ratio for SIMULATIONS PLUS INC (SLP) is 28.17 and the Price/Book (PB) ratio is 2.98.


Can you provide the dividend sustainability for SLP stock?

The dividend rating of SIMULATIONS PLUS INC (SLP) is 4 / 10 and the dividend payout ratio is -1.9%.